MAALOX Chewable tablet

Indications

Symptomatic treatment of disorders due to hyperacidity in:

- gastritis

- hiatal hernia

- dyspepsia

- peptic ulcer

Dosage and administration

For adults ONLY (from 15 years old).

1 to 2 tablets to be chewable after meals or when pain (or malaise) occurs.

Maximum daily dose: 6 doses. Do not exceed 12tablets/day. Chew the tablet as carefully as possible.

This drug should never be used in the following events:

- Hypersensitivity to any of the components of the tablet.

- Severe renal insufficiency, due to the presence of magnesium.

Possible onset of:

- transit disorders (diarrhea or constipation),

- phosphorus depletion after long-term use or high doses, due to the presence of aluminium.

Combinations requiring precautions for use:

There is a decrease in the gastrointestinal absorption of medicinal products taken simultaneously. As a precautionary measure, it is advisable to take antacids well before or after taking other drugs.

If possible, take at least 2 hours before or after the following drugs: H2 antihistamines, anti-tuberculosis drugs: ethambutol, isoniazide (oral route), atenolol, metoprolol, propanolol, chloroquine, cyclones, diflunisal, digoxin, diphosphonates, fexofenadine, iron (salts), fluoroquinolones, sodium fluoride, glucocorticosteroids (described for prednisolone and dexamethasone), indomethacin, kayexalate, ketoconazole, lanzoprazole, lincosamide, phenothiazine neuroleptics, penicillamine, phosphorus (supplements), thyroxine.

Combinations to take into account:

Salicylates: increased renal excretion of salicylates due to urine alkalinization.

Pregnancy:

This product should only be used during pregnancy if necessary.

Take into account the presence of aluminium and magnesium ions susceptible to slowdown transit.

- magnesium hydroxide salts may induce diarrhea,

- aluminium salts are at the origin of constipation and may exacerbate constipation occurring generally during pregnancy.

This product should not be taken at high doses or over long periods.

Lactation

Breast-feeding can be continued during treatment.

Because of the presence of sorbitol and sucrose, this medicinal product is contraindicated in the event of fructose intolerance, glucose or galactose malabsorption syndrome, or any sucrose-isomaltase deficiency.

In patients presenting with renal insufficiency or undergoing chronic dialysis, the aluminium content of this product must be taken into consideration (risk of encephalopathy).

If disorders persist for more than 10 days, or if they get worse, screening for etiology should be carried out and treatment reassessed.